Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2020 Mar-Apr:34:101658.
doi: 10.1016/j.tmaid.2020.101658. Epub 2020 Apr 2.

Repurposing antimalarials and other drugs for COVID-19

Patricia Schlagenhauf  1 , Martin P Grobusch  2 , Julian D Maier  3 , Philippe Gautret  4
Affiliations
Editorial

Repurposing antimalarials and other drugs for COVID-19

Patricia Schlagenhauf et al. Travel Med Infect Dis. 2020 Mar-Apr.
No abstract available

PubMed Disclaimer

References

    1. Rothe C., Schunk M., Sothmann P., Bretzel G., Froeschl G., Wallrauch C., Zimmer T., Thiel V., Janke C., Guggemos W., Seilmaier M., Drosten C., Vollmar P., Zwirglmaier K., Zange S., Wölfel R., Hoelscher M. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020 Mar 5;382(10):970–971. doi: 10.1056/NEJMc2001468. - DOI - PMC - PubMed
    1. Ebrahim S.H., Ahmed Q.A., Gozzer E., Schlagenhauf P., Memish Z.A. COVID-19 and community mitigation strategies in a pandemic. BMJ. 2020 Mar 17;368:m1066. doi: 10.1136/bmj.m1066. - DOI - PubMed
    1. Yao X., Ye F., Zhang M., Cui C., Huang B., Niu P., Liu X., Zhao L., Dong E., Song C., Zhan S., Lu R., Li H., Tan W., Liu D. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of Severe Acute Respiratory Syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis. 2020 Mar 9 doi: 10.1093/cid/ciaa237. pii: ciaa237. - DOI - PMC - PubMed
    1. Gautret P., Lagier J.C., Parola P., Hoang V.T., Meddeb L., Mailhe M., Doudier B., Courjon J., Giordanengo V., Vieira V.E., Dupont H.T., Honoré S., Colson P., Chabrière E., La Scola B., Rolain J.M., Brouqui P., Raoult D. Hydroxychloroquine and azithromycin as a treatment of COVID‐19: results of an open‐label non‐randomized clinical trial. Int J Antimicrob Agents. 2020 Mar 20:105949. doi: 10.1016/j.ijantimicag.2020.105949. - DOI - PMC - PubMed
    1. Zhou F., Yu T., Du R., Fan G., Liu Y., Liu Z., Xiang J., Wang Y., Song B., Gu X., Guan L., Wei Y., Li H., Wu X., Xu J., Tu S., Zhang Y., Chen H., Cao B. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 11 doi: 10.1016/S0140-6736(20)30566-3. pii: S0140-6736(20)30566-3. - DOI - PMC - PubMed

Publication types